These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21260956)

  • 1. Acetazolamide therapy in meningeal involvement of nephrogenic systemic fibrosis.
    Geara AS; El-Imad B; El-Sayegh S
    Intern Med J; 2010 Dec; 40(12):e4-5. PubMed ID: 21260956
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic fibrosing dermopathy.
    Ragunatha S; Palit A; Inamadar AC; Madraki RM; Yelikar BR
    Indian J Dermatol Venereol Leprol; 2009; 75(1):63-7. PubMed ID: 19172035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
    Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.
    Elmholdt TR; Pedersen M; Jørgensen B; Ramsing M; Olesen AB
    Acta Derm Venereol; 2011 Jun; 91(4):478-9. PubMed ID: 21537826
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
    Bernstein EJ; Schmidt-Lauber C; Kay J
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleral Plaques in Nephrogenic Systemic Fibrosis.
    Dreyer S; Rodriguez L; Worswick S
    Cutis; 2022 Jan; 109(1):E31-E32. PubMed ID: 35180067
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrogenic systemic fibrosis in a gadolinium-naïve patient: successful treatment with oral sirolimus.
    Ross C; De Rosa N; Marshman G; Astill D
    Australas J Dermatol; 2015 Aug; 56(3):e59-62. PubMed ID: 25330850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which laboratory parameters are characteristic for nephrogenic systemic fibrosis?
    Boehm I
    Nephrol Dial Transplant; 2009 Jul; 24(7):2293; author reply 2293-4. PubMed ID: 19357110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephrogenic fibrosing dermatosis: From clinic to microscopy].
    Yoldez H; Ahlem B; Abderrahim E; Faten Z; Soumaya R
    Nephrol Ther; 2018 Feb; 14(1):47-49. PubMed ID: 29239786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation.
    Fuah KW; Lim CTS
    BMC Nephrol; 2017 Jul; 18(1):249. PubMed ID: 28738858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrogenic fibrosing dermatopathy].
    Zelger B
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):428, 430-1. PubMed ID: 16295135
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis in the podiatric patient.
    Freed L; Hill J; Gooch D
    J Am Podiatr Med Assoc; 2012; 102(5):419-21. PubMed ID: 23001737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrogenic fibrosing dermopathy].
    Brisch M; Schneider T; Requena L; Mentzel T; Kutzner H
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):464-7. PubMed ID: 16295140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis.
    Kreuter A; Gambichler T; Weiner SM; Schieren G
    Arch Dermatol; 2008 Nov; 144(11):1527-9. PubMed ID: 19015438
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause.
    Provenzale JM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1867-9. PubMed ID: 19020262
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrogenic Systemic Fibrosis.
    Sarwal A; Gnanasekaran I
    Am J Med Sci; 2021 Jan; 361(1):e5-e6. PubMed ID: 32709396
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis.
    Wiginton CD
    AJR Am J Roentgenol; 2008 Dec; 191(6):1864-6. PubMed ID: 19020261
    [No Abstract]   [Full Text] [Related]  

  • 18. What is your diagnosis. Nephrogenic systemic fibrosis.
    Zaleski L; Xia Y; Cho S
    Cutis; 2011 Jan; 87(1):13, 19-20. PubMed ID: 21323094
    [No Abstract]   [Full Text] [Related]  

  • 19. Alefacept therapy for nephrogenic systemic fibrosis: a case series.
    Robinson MR; Routhouska SB; Paspulati RM; Korman NJ
    J Drugs Dermatol; 2011 Aug; 10(8):922-4. PubMed ID: 21818517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of nephrogenic systemic fibrosis on radiology examinations.
    Morris MF; Zhang Y; Zhang H; Prowda JC; Silvers DN; Fawwaz RA; Prince MR
    AJR Am J Roentgenol; 2009 Jul; 193(1):61-9. PubMed ID: 19542396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.